Skip to main content
7 November 2025
Last updated:
Thursday 6 November 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Europe's capital markets continue to struggle
Read more
Changes in the landscape for genome editing
Read more
ASCO 2024
Read more
More advanced planning needed for antimicrobials
Read more
New antibiotics pass regulatory hurdles
Read more
EU prepares for expansion of biotech
Read more
Long overdue, the EU capital markets plan is revived
Read more
Swiss biotech helped by international deals, drug wins, By Jane Morrison
Read more
GLP-1 agonists shake up the sector
Read more
New oncology drugs in pre-registration, late stage development
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
